Landscapes / Targets

CSF-1R

12 drugs act on CSF-1R, in 34 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs12

DrugHow it worksCompanyStageNext dateDetails
Monoclonal antibody
Incyte +1
Approved 6 Jan 2027Phase 1/2 trial completes
Tyrosine kinase inhibitor
Approved in China 31 May 2028Phase 2/3 trial completes
Kinase inhibitor
Approved Aug 2028Phase 1/2 trial completes
Tyrosine kinase inhibitor
Phase 3 Dec 2026Phase 3 trial completes
Tyrosine kinase inhibitor
Phase 3 30 Jan 2027Phase 1/2 trial completes
—
Phase 3 28 Feb 2027Phase 2 trial completes
Tyrosine kinase inhibitor
Phase 3 29 Nov 2027Phase 2 trial completes
Monoclonal antibody
Phase 3 —
Tyrosine kinase inhibitor
Phase 1/2 30 Dec 2027Phase 1/2 trial completes
—
Phase 1/2 —
—
Phase 1 Aug 2027Phase 1 trial completes
Tyrosine kinase inhibitor
Turning Point Therapeutics +1 · Public BMY
Phase 1 —

About this list

Checked
12 of 12 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow CSF-1R

Following is part of Solo: you see every change to CSF-1R the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in